Although the PDE inhibitor was given in two different regimens, a bigger study with over 300 children with DMD who were divided into groups, treated with tadalafil and control, revealed no difference between the PDE inhibitor and boys who received a placebo (who were all taking standard GCs). This evidence concerns the gene ALDH7A1 and Duchenne muscular dystrophy.